Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| GHK-Cu | HGH (Somatropin) | |
|---|---|---|
| Category | Growth Factors | Growth Factors |
| Standard Dose | Research indicates 1-2 mg daily via subcutaneous injection, or topical application at 1-3% concentration in cream/serum. | Research indicates 1-2 IU daily for anti-aging and general optimization. 2-4 IU daily for body composition. 4-8+ IU daily in clinical GH deficiency (physician-supervised only). |
| Timing | Evening administration preferred for skin rejuvenation (aligns with nocturnal repair cycles). Topical can be applied morning and evening. | Bedtime injection (mimics natural nocturnal GH surge) or morning fasted. Split dosing (AM + pre-bed) for higher doses. Always on empty stomach — carbohydrates blunt GH action. |
| Cycle Duration | 8-12 weeks for injectable cycles. Topical use can be ongoing. | Continuous use is common in anti-aging protocols. 6-12 month minimum for full benefits. Clinical GHD treatment is typically lifelong. |
| Evidence Level | moderate_human | strong_human |
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that modulates gene expression affecting 31.2% of human genes. It activates Wnt/beta-catenin signaling for hair follicle growth, stimulates TGF-beta pathway for tissue remodeling, and promotes collagen and glycosaminoglycan synthesis while modulating metalloproteinase activity. The copper ion serves as a cofactor for enzymes essential to wound healing including superoxide dismutase and lysyl oxidase.
Research indicates 1-2 mg daily via subcutaneous injection, or topical application at 1-3% concentration in cream/serum.
Evening administration preferred for skin rejuvenation (aligns with nocturnal repair cycles). Topical can be applied morning and evening.
8-12 weeks for injectable cycles. Topical use can be ongoing.
Human Growth Hormone (somatropin) is a 191-amino acid single-chain polypeptide produced by anterior pituitary somatotrophs. It binds the GH receptor (GHR), activating JAK2-STAT5 signaling and MAP kinase pathways. Systemically, HGH upregulates hepatic IGF-1 production, which mediates most of its anabolic effects through IGF-1R/PI3K/Akt/mTOR-driven protein synthesis. Direct GH effects include lipolysis activation, insulin antagonism, chondrocyte/osteoblast stimulation, and enhanced collagen synthesis. Effects are divided into direct (lipolysis, insulin antagonism) and indirect (IGF-1-mediated growth and anabolism).
Research indicates 1-2 IU daily for anti-aging and general optimization. 2-4 IU daily for body composition. 4-8+ IU daily in clinical GH deficiency (physician-supervised only).
Bedtime injection (mimics natural nocturnal GH surge) or morning fasted. Split dosing (AM + pre-bed) for higher doses. Always on empty stomach — carbohydrates blunt GH action.
Continuous use is common in anti-aging protocols. 6-12 month minimum for full benefits. Clinical GHD treatment is typically lifelong.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →